Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Feb 29;34:102028. doi: 10.1016/j.ajoc.2024.102028

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Authors

This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

PMC Copyright notice

Fig. 1 — Optical coherence tomography imaging of the left eye at baseline and examinations following erdafitinib initiation. (A) Baseline OCT prior to erdafitinib initiation showing epiretinal membrane without significant outer retinal alterations. (B) 47 days after erdafitinib initiation, new subretinal material accumulation is present with EZ-RPE distance changes and EZ disruption. (C) Six month OCT with new SRF accumulation. (D) Twelve month OCT showing some improvement in outer retinal alterations following erdafitinib dose reduction.